Antiaging Quantum Living (AAQL) EBIT Margin (2019 - 2025)

Antiaging Quantum Living's EBIT Margin history runs 7 years deep, the most recent figure standing at 80.0% for Q4 2025.

• In Q4 2025, EBIT Margin rose 4870.0% year-over-year to 80.0%; the TTM figure through Dec 2025 stood at 48.94% (up 11574.0% YoY), while the FY2025 annual figure was 96.58%, up 541104.0% from the prior year.
• EBIT Margin came in at 80.0% for Q4 2025 at Antiaging Quantum Living, down from 13.13% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 13.13% in Q3 2025 to a low of 2477.25% in Q2 2023.
• A 5-year average of 545.8% and a median of 169.3% in 2022 frame the typical range for EBIT Margin.
• Across the five-year window, EBIT Margin soared 481325 bps in 2021 and sank 159788 bps in 2023, its largest moves.
• Antiaging Quantum Living's EBIT Margin stood at 1379.29% in 2021, then soared by 88 bps to 169.3% in 2022, then plunged by 810 bps to 1541.4% in 2023, then soared by 92 bps to 128.71% in 2024, then surged by 38 bps to 80.0% in 2025.
• According to Business Quant data, EBIT Margin over the past three periods registered 80.0%, 13.13%, and 47.42% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison